Advancing precision-based antimicrobial dosing in critically ill patients
Intensive Care Med
.
2023 Mar;49(3):324-326.
doi: 10.1007/s00134-022-06969-7.
Epub 2023 Jan 25.
Authors
Menino O Cotta
1
,
Jeffrey Lipman
2
3
4
,
Jan De Waele
5
6
Affiliations
1
UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia. m.o.cotta@uq.edu.au.
2
UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
3
Department of Intensive Care Medicine, Royal Brisbane and Women's hospital, Butterfield Street, Herston, Brisbane, QLD, Australia.
4
Jamieson Trauma Institute, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD, Australia.
5
Dept of Intensive Care Medicine, University Hospital Ghent, 60200, Gent, Oost-Vlaanderen, Belgium.
6
Faculty of Medicine and Health Sciences, Internal Medicine and Pediatrics, Ghent University, Gent, 54498, Belgium.
PMID:
36695835
DOI:
10.1007/s00134-022-06969-7
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents* / therapeutic use
Critical Illness* / therapy
Humans
Substances
Anti-Infective Agents
Anti-Bacterial Agents